Modified titanium implant as a gateway to the human body: The implant mediated drug delivery system

12Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study was to investigate the efficacy of a proposed new implant mediated drug delivery system (IMDDS) in rabbits. The drug delivery system is applied through a modified titanium implant that is configured to be implanted into bone. The implant is hollow and has multiple microholes that can continuously deliver therapeutic agents into the systematic body. To examine the efficacy and feasibility of the IMDDS, we investigated the pharmacokinetic behavior of dexamethasone in plasma after a single dose was delivered via the modified implant placed in the rabbit tibia. After measuring the plasma concentration, the areas under the curve showed that the IMDDS provided a sustained release for a relatively long period. The result suggests that the IMDDS can deliver a sustained release of certain drug components with a high bioavailability. Accordingly, the IMDDS may provide the basis for a novel approach to treating patients with chronic diseases.

Cite

CITATION STYLE

APA

Park, Y. S., Cho, J. Y., Lee, S. J., & Hwang, C. I. (2014). Modified titanium implant as a gateway to the human body: The implant mediated drug delivery system. BioMed Research International, 2014. https://doi.org/10.1155/2014/801358

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free